Plasticell delivers stem cell differentiation protocols to Stemnion
11 August 2011
Plasticell has announced the successful completion of a
collaboration with Stemnion, Inc. Plasticell used its flagship
technology CombiCult to discover multiple novel, serum-free protocols
that direct the differentiation of Stemnion’s human placenta-derived
stem cells into hard-to-obtain lineages.
The protocols were ranked using Plasticell’s Ariadne bioinformatics
software and subsequently validated by Stemnion scientists.
“Using CombiCult's combinatorial technology, we identified
several differentiation protocols for our cells at a fraction of the
time, resources and cost compared to conventional trial-and-error
methods,” said Randall Rupp, Vice-President, Manufacturing and
Development, Stemnion, Inc.
“This project once again demonstrates the flexibility and the
power of CombiCult to push the differentiation of adult stem cells
into various lineages,” said Dr. Lilian Hook, Director of Research
at Plasticell. “Stemnion provided us with a challenge that is
typical of adult stem cell R&D programmes, however this project was
particularly interesting on several fronts, including, for the first
time, utilising placenta-derived stem cells as the starting